PRIMARY STUDY

Symptoms and Extraintestinal Manifestations in Active Cannabis Users with Inflammatory Bowel Disease

Key Findings:  Data suggests that cannabis using patients did not demonstrate more frequent active disease or IBD-associated complications. As such, the authors posit that other non-luminal (organ cavity) factors influenced their symptoms and/or decision to use cannabis.

Type of Study:  Meta-analysis

Study Sample Size:  383

Study Result:  Inconclusive

Study Location(s):  United States

Year of Pub:  2021


Cannabinoids Studied:  Cannabinoid (unspecified)

Phytocannabinoid Source:  Unspecified